Mesostigmata mite control agent
AssigneeMeiji Seika Pharma Co., Ltd.
InventorsSatoshi Nakamura, Takehiko Inoue, Haruka Takeuchi
Life of this patent
Estimating the term…
Abstract
A control agent comprising, as an active ingredient, a specific quinoline derivative compound such as 8-fluoro-2,3-dimethyl-6-(1,1-dimethylethyl)-4-(methylcarbonyl)oxyquinoline, azoxystrobin, picoxystrobin, pyraclostrobin, kresoxim-methyl, trifloxystrobin, metominostrobin, orysastrobin, famoxadone, fluoxastrobin, pyribencarb, cyazofamid, amisulbrom, flutolanil, mepronil, isofetamid, fluopyram, carboxin, thifluzamide, fluxapyroxad, furametpyr, penflufen, penthiopyrad, boscalid, diflumetorim, fluazinam, ferimzone, fenpyroximate, or an acid addition salt of any of these compounds shows an excellent controlling effect on Mesostigmata mites.
Claims5
A Mesostigmata mite control method, said method comprising
- applying an effective amount of at least one active ingredient selected from the group consisting of compounds represented by the following Formula (1), and acid addition salts of these compounds, to at least one selected from the group consisting of a Mesostigmata mite, a homoiotherm, an insect, a habitat of a Mesostigmata mite, a habitat of a homoiotherm, and a habitat of an insect:
- wherein in Formula (1), R1 is —COCH3;
- and R2 is F or —CH3;
- and R3 is a t-Bu group.
Dependencies are inferred from the claim text.